# US 2021/0228116 A1 · Ecg-based glucose monitoring system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228116 A1
- Document ID: US20210228116A1
- Status: Published application
- Kind: A1
- Application number: 17/159,758
- Filed: 2021-01-27
- Published: 2021-07-29
- Earliest claimed: 2020-01-29
- Assignees: Anexa Labs LLC
- Applicants: Anexa Labs LLC
- Inventors: Alexey Reykhert
- Web page: https://patentgrep.com/patent/US20210228116A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/02427: {Details of sensor}
- A61B 5/28: for electrocardiography [ECG]
- A61B 5/346: Analysis of electrocardiograms
- A61B 5/7203: {for noise prevention, reduction or removal}
- A61B 5/7278: {Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals}
- A61B 5/02416: {using photoplethysmograph signals, e.g. generated by infrared radiation (A61B5/14552 takes precedence)}
- A61B 5/0537: Measuring body composition by impedance, e.g. tissue hydration or fat content
- A61B 5/332: Portable devices specially adapted therefor
- A61B 5/7267: {involving training the classification device}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 2560/0223: of calibration, e.g. protocols for calibrating sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Disclosed herein are systems and methods for non-invasively monitoring blood glucose levels with a level of accuracy that is high enough to replace invasive methods such as finger prick devices and others. In some examples, glucose values are determined using a patient's electrocardiogram (ECG) signals. Additionally, glucose values may additionally be determined using an impedance spectroscopy based method and then combined with glucose values determined using an ECG waveform to output a blood glucose value.

## Claims

### Claim 1

A system for monitoring glucose values of a patient, the system comprising:
at least two electrodes configured to output electrical data;
a display;
a memory;
a control system coupled to the memory comprising one or more processors, the control system configured to execute a machine executable code to cause the control system to:
receive a set of electrical data output from the at least two electrodes;
process the set of electrical data to output a set of electrocardiogram (ECG) features;
process the set of ECG features to output an ECG-based blood glucose level; and
store the ECG-based blood glucose level in the memory;
wherein process the set of ECG features to output the ECG-based blood glucose level comprises determining the ECG-based blood glucose level based on amplitude difference ratios of the set of ECG features and time difference ratios of the set of ECG features.

### Claim 2 (depends on 1)

The system of claim 1, wherein the control system is further configured to display the ECG-based blood glucose level on the display.

### Claim 3 (depends on 1)

The system of claim 1, wherein the set of ECG features comprises amplitude differences between ECG points.

### Claim 4 (depends on 1)

The system of claim 1, wherein the set of ECG features comprises a QS amplitude difference, a QR amplitude difference, a TR amplitude difference, and an ST amplitude difference; wherein the QS amplitude difference is a difference between Q and S ECG points; wherein the QR amplitude difference is a difference between Q and R ECG points; wherein the TR amplitude difference is a difference between T and R ECG points; and wherein the ST amplitude difference is a difference between S and T ECG points.

### Claim 5 (depends on 4)

The system of claim 4, wherein process the set of ECG features further comprises process the ECG features according to an equation C1*(the QS Amplitude difference/the QR Amplitude difference+the TR Amplitude difference/the ST Amplitude difference)+C2*(a Q-T interval/a Q-S interval); wherein C1 and C2 are determined by experimentation using a data set output from an invasive glucose meter reading.

### Claim 6 (depends on 1)

The system of claim 1, wherein the control system is configured to process an impedance-based glucose value and the ECG-based blood glucose level to output an adapted glucose value.

### Claim 7 (depends on 6)

The system of claim 6, further comprising an electronic control system connected to the at least two electrodes and configured to control a voltage applied to the at least two electrodes.

### Claim 8 (depends on 7)

The system of claim 7, wherein the voltage comprises a sinusoidal voltage.

### Claim 9 (depends on 7)

The system of claim 7, wherein the control system is further configured to:
provide instructions to the electronic control system to apply a sinusoidal voltage to the at least two electrodes;
determine a set of impedance measurements based on electrical data output from the at least two electrodes; and
process the set of impedance measurements to output the impedance-based glucose value.

### Claim 10 (depends on 9)

The system of claim 9, wherein apply the sinusoidal voltage comprises applying a set of sinusoidal frequencies in a range of 10 MHz-200 MHz.

### Claim 11 (depends on 9)

The system of claim 9, wherein apply the sinusoidal voltage comprises applying a set of sinusoidal frequencies in a range of 1 MHz-160 MHz.

### Claim 12 (depends on 9)

The system of claim 9, wherein process the set of impedance measurements to output the impedance-based glucose value further comprises calibration with temperature values, amplitudes of QRS complex values, and heart rate values using a linear equation.

### Claim 13 (depends on 6)

The system of claim 6, wherein process the impedance-based glucose value and the ECG-based blood glucose level to output the adapted glucose value comprises combining the impedance-based glucose value and the ECG-based glucose level with a linear formula.

### Claim 14 (depends on 13)

The system of claim 13, wherein the linear formula comprises summing the impedance-based glucose value multiplied by a first coefficient and the ECG-based blood glucose level multiplied by a second coefficient.

### Claim 15 (depends on 6)

The system of claim 6, wherein the process the impedance-based glucose level and the ECG-based blood glucose level to output the adapted glucose level is performed using linear regression.

### Claim 16 (depends on 1)

The system of claim 1, wherein process the set of electrical data to output the set of ECG features comprises process the set of ECG features to output a set of clean ECG features; and process the set of clean ECG features to output an ECG-based blood glucose level; wherein process the set of ECG features to output the set of clean ECG features comprises eliminating ECG features in the set of ECG features that are outside a threshold.

### Claim 17 (depends on 16)

The system of claim 16, wherein process the set of ECG features to output the set of clean ECG features further comprises eliminating any features in the set of ECG features that have a level of noise above a threshold.

### Claim 18

A method for monitoring glucose values of a patient, the method comprising:
acquiring, via at least two electrodes, a set of electrical data;
receiving, via a control system, the set of electrical data from the at least two electrodes;
processing, via the control system, the set of electrical data to output a set of ECG features;
processing, via the control system, the set of ECG features to output an ECG-based blood glucose level; and
display the ECG-based blood glucose level on the display;
wherein processing the set of ECG features to output the ECG-based blood glucose level comprises determining the ECG-based blood glucose level according to amplitude difference ratios of the set of ECG features and time difference ratios of the set of ECG features.

### Claim 19 (depends on 19)

The method of claim 19, wherein the set of ECG features comprises a QS amplitude difference, a QR amplitude difference, a TR amplitude difference, and an ST amplitude difference; wherein the QS amplitude difference is a difference between Q and S ECG points; wherein the QR amplitude difference is a difference between Q and R ECG points; wherein the TR amplitude difference is a difference between T and R ECG points; and wherein the ST amplitude difference is a difference between S and T ECG points.

### Claim 20 (depends on 18)

The method of claim 18, wherein processing the set of ECG features further comprises processing the ECG features according to an equation C1*(the QS Amplitude difference/the QR Amplitude difference+the TR Amplitude difference/the ST Amplitude difference)+C2*(a Q-T interval/a Q-S interval); wherein C1 and C2 are determined by experimentation using a data set output from an invasive glucose meter reading.
